SCHEMBL7899165

SCHEMBL7899165

O=C(CCCc1ccccc1)NC1CCN(c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ME3 Q16798 1/20 0.58
EPHX2 P34913 2/20 0.57
CHRM4 P08173 1/20 0.53
EPHX1 P07099 1/20 0.53
LTA4H P09960 2/20 0.52
FFAR4 Q5NUL3 3/20 0.51
MAPT P10636 2/20 0.51
RAB9A P51151 1/20 0.51
LMNA P02545 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HTT P42858 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49
ENPP2 Q13822 1/20 0.48
KDM1A O60341 1/20 0.48
MAOA P21397 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7898002 0.88 ME3 (0.76) ME3EPHX2CHRM4MAPTRAB9A
SCHEMBL7902716 0.81 TP53 (0.60) ME3CHRM4MAPTALDH1A1CYP1A2
SCHEMBL7899170 0.81 LTA4H (0.56) ME3LTA4HMAPTRAB9ALMNA
SCHEMBL7898015 0.80 KDM4E (0.54) EPHX2LTA4H
SCHEMBL12321963 0.79 CKS1B (0.53) ME3CHRM4MAPTRAB9ALMNA
SCHEMBL7902701 0.78 FOXM1 (0.53) ME3MAPTLMNAALDH1A1HTT
SCHEMBL7899149 0.78 EPHX2 (0.54) EPHX2LTA4HFFAR4MAPTRAB9A
SCHEMBL27546385 0.78 EPHX2 (0.54) EPHX2LTA4HFFAR4MAPTRAB9A
SCHEMBL23395780 0.77 EPHX2 (0.85) EPHX2EPHX1RAB9ALMNACYP1A2
SCHEMBL20887689 0.77 ACACB (0.61) ME3LTA4HMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed